Cost Comparison of Transcarotid Arterial Revascularization With Carotid Endarterectomy and Transfemoral Carotid Stenting

Abstract

Transcarotid arterial revascularization (TCAR) has been associated with a lower risk of stroke or death compared with transfemoral carotid artery stenting (TFAS) and a lower risk of cranial nerve injury and myocardial infarction than carotid endarterectomy (CEA). To the best of our knowledge, no comparative studies have been performed of the costs between TCAR, CEA, and TFAS, which could have important implications on institutional support for the new modality to address carotid artery stenosis.